| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.2 |